Recombinant Human Olfactory receptor 1B1 (OR1B1)

What is the basic structure of human OR1B1 and how does it compare to other olfactory receptors?

OR1B1 (olfactory receptor 1B1) is a 318 amino acid protein belonging to the class A G-protein-coupled receptor (GPCR) family. Like other olfactory receptors, it features the canonical GPCR structure with seven transmembrane domains (7TM), three intracellular loops (ICL), and three extracellular loops (ECL) . The gene encoding OR1B1 maps to human chromosome 9q33.2 .

Olfactory receptors constitute the largest transmembrane protein family in the human genome, with OR1B1 representing one specific member of this diverse family . Structurally, OR1B1 shares the fundamental GPCR architecture with other olfactory receptors, though specific binding pocket configurations vary between different OR subtypes, directly influencing ligand specificity and binding affinities .

What is the functional role of OR1B1 in the olfactory signaling pathway?

OR1B1 localizes to the cilia of olfactory sensory neurons where it binds specific odor molecules, functioning as a chemical sensor in the olfactory system . Upon odorant binding, OR1B1 undergoes conformational changes that activate associated G proteins, triggering a signal transduction cascade . This cascade involves secondary messenger systems, ultimately leading to action potential generation and signal transmission to the brain for odor perception .

The specific odorant recognition properties of OR1B1 contribute to the combinatorial coding system used by mammals to discriminate between thousands of different odorants . Within this system, individual odorants can activate multiple receptor types, and a single receptor can respond to multiple odorants, though with varying affinities—creating unique activation patterns that the brain interprets as specific odors .

How does the binding mechanism of OR1B1 compare with other characterized olfactory receptors?

While the specific binding mechanism of OR1B1 has not been fully characterized in the provided search results, insights from other olfactory receptors provide valuable comparative information. Recent studies of OR51E2 revealed that this receptor entraps odorant molecules (specifically propionic acid) within a compact, enclosed binding pocket measuring approximately 31 ų .

The binding involves both polar interactions (hydrogen and ionic bonds) and non-specific hydrophobic interactions . The size of the binding pocket directly influences ligand selectivity—OR51E2's compact pocket accommodates only short-chain fatty acids while excluding longer chains . By analogy, OR1B1 likely possesses a distinctive binding pocket architecture that determines its specific odorant recognition profile, though the exact dimensions and ligand preferences require further investigation through techniques such as molecular dynamics simulations and structural studies .

What are the most effective expression systems for producing recombinant OR1B1 protein?

Based on successful approaches with other olfactory receptors, the most effective expression system for recombinant OR1B1 production appears to be mammalian cell lines, particularly HEK293S cells with tetracycline-inducible expression systems . This approach has demonstrated success with hOR1A1, another human olfactory receptor .

Methodological considerations include:

• Vector design: Engineering the OR1B1 gene with epitope tags (such as C-terminal rho1D4 and N-terminal FLAG tags) to facilitate purification and detection

• Cell line selection: Using stable tetracycline-inducible HEK293S cells to provide controlled expression

• Expression conditions: Optimizing induction parameters, culture conditions, and harvest timing to maximize protein yield while maintaining proper folding

• Scale considerations: Planning for adequate production scale, as reference studies with similar olfactory receptors required sixty T175 flasks to yield approximately 2.7 mg of purified protein (combined monomeric and dimeric forms)

This expression strategy allows for proper post-translational modifications and membrane insertion that are critical for maintaining the native conformation and function of GPCRs like OR1B1.

What purification strategies yield the highest purity and functional integrity for OR1B1?

For optimal purification of recombinant OR1B1 while maintaining functional integrity, a multi-step approach is recommended based on successful purification of similar olfactory receptors:

• Solubilization: Carefully solubilize membrane fractions using appropriate detergents that preserve receptor structure and function

• Affinity chromatography: Implement monoclonal anti-FLAG immunoaffinity purification as a first step if using FLAG-tagged constructs

• Size exclusion chromatography: Follow with gel filtration to separate receptor forms (monomeric vs. dimeric) and remove aggregates

• Quality assessment: Verify proper folding using circular dichroism analysis, which can confirm the presence of characteristic α-helical secondary structure expected for GPCRs

• Functional verification: Conduct ligand binding assays, such as intrinsic tryptophan fluorescence assays, to confirm that the purified receptor maintains binding capability

The expected outcome includes separation of monomeric and dimeric forms of the receptor, with functional binding properties maintained in the detergent-solubilized state .

How can the functional activity of recombinant OR1B1 be reliably measured in vitro?

Several complementary approaches can be used to reliably assess the functional activity of recombinant OR1B1 in vitro:

• Real-time cAMP assays: Measure receptor activation through quantification of cAMP production in response to potential ligands, as demonstrated with other olfactory receptors in heterologous expression systems

• Intrinsic tryptophan fluorescence assays: Quantify ligand binding through changes in fluorescence when potential odorants interact with tryptophan residues in the receptor binding pocket

• Calcium imaging: Monitor changes in intracellular calcium levels upon receptor activation using fluorescent calcium indicators

• Electrophysiological recordings: For more sensitive measurements, patch-clamp techniques can detect ion channel activity downstream of receptor activation

• GTPγS binding assays: Measure G protein activation directly through quantification of non-hydrolyzable GTP analog binding

Each of these methodologies offers different advantages in terms of sensitivity, throughput, and the specific aspect of receptor function being measured. A comprehensive functional characterization would typically employ multiple complementary approaches to build a complete profile of receptor activity.

How can molecular dynamics simulations be applied to study OR1B1 ligand interactions?

Molecular dynamics (MD) simulations offer powerful approaches for investigating OR1B1-ligand interactions that may be difficult to study through experimental methods alone:

• Conformational dynamics: MD can simulate the structural dynamics of OR1B1, including transitions between active and inactive states, providing insights into receptor flexibility and mechanism of activation

• Binding mode analysis: Simulations can reveal detailed binding poses of potential ligands, identifying key residues involved in recognition and binding affinity determination

• Binding pocket characterization: MD allows precise measurement of binding pocket volume and properties, critical for understanding ligand selectivity as demonstrated in studies of OR51E2

• Activation mechanism elucidation: Simulations can track conformational changes during receptor activation, including how ECL3 structural alterations propagate to initiate G protein coupling

• Novel ligand prediction: By understanding binding characteristics, MD can support virtual screening efforts to predict new agonists or antagonists for OR1B1

Implementation typically involves:

• Generating a structural model of OR1B1 using AlphaFold2 or homology modeling if experimental structures are unavailable

• Embedding the receptor in a lipid bilayer with appropriate membrane composition

• Simulating the system for sufficient time to observe relevant dynamics (typically microseconds)

• Analyzing trajectory data for binding interactions and conformational changes

These approaches complement experimental studies by providing atomic-level insights into binding mechanisms and receptor activation processes .

What strategies can overcome the challenges of OR1B1 crystallization for structural studies?

Crystallization of GPCRs like OR1B1 presents significant challenges due to their hydrophobic nature, conformational flexibility, and relatively low natural expression levels. Based on advances with other receptors, several strategies can be employed:

• Protein engineering approaches:

  • Introduction of stabilizing mutations identified through alanine scanning or computational prediction

  • Fusion with crystallization-promoting proteins such as T4 lysozyme or BRIL

  • Truncation of flexible N- and C-terminal domains that may impede crystal formation

  • Introduction of disulfide bonds to restrict conformational flexibility

• Ligand-based stabilization:

  • Co-crystallization with high-affinity ligands to stabilize a specific conformation

  • Screening libraries of odorants to identify compounds that enhance thermostability

• Alternative structural methods:

  • Cryo-electron microscopy, which has recently proven successful for other olfactory receptors

  • Lipidic cubic phase crystallization specifically designed for membrane proteins

  • Integration of computational approaches with limited experimental data

• Expression optimization:

  • Use of specialized HEK293S GnTI⁻ cells to reduce glycosylation heterogeneity

  • Implementation of nanobodies to stabilize specific conformational states

The results from these approaches would ideally lead to high-resolution structural data revealing the binding pocket architecture and molecular basis for ligand specificity of OR1B1, comparable to recent advances with OR51E2 .

How can knockout/knockdown models be developed to study OR1B1 function in vivo?

Developing effective knockout/knockdown models for OR1B1 functional studies requires strategic approaches tailored to the unique challenges of olfactory receptor research:

• siRNA knockdown approach:

  • Utilization of OR1B1-specific siRNA pools, such as those commercially available, containing target-specific 19-25 nt siRNAs designed to knock down gene expression

  • Implementation in cell culture models expressing OR1B1 to assess functional consequences

  • Validation of knockdown efficiency through qPCR and Western blot analysis

• CRISPR-Cas9 genome editing:

  • Design of guide RNAs targeting exonic regions of OR1B1

  • Generation of knockout cell lines for in vitro functional studies

  • Development of animal models with tissue-specific OR1B1 deletion in olfactory epithelium

  • Phenotypic characterization through behavioral assays and electrophysiological recordings

• Conditional knockout strategies:

  • Implementation of Cre-loxP systems for temporal and spatial control of OR1B1 deletion

  • Use of olfactory sensory neuron-specific promoters (e.g., OMP promoter) to drive Cre expression

  • Induction of knockout at specific developmental stages to distinguish between developmental and functional roles

• Validation and phenotyping:

  • Odorant response profiling using calcium imaging or electrophysiological recordings

  • Behavioral testing to assess olfactory discrimination and sensitivity

  • Molecular analysis of compensatory changes in other olfactory receptor expression

These approaches enable systematic investigation of OR1B1's specific contribution to olfactory coding and signal transduction, providing insights into its biological function that complement the structural and biochemical studies described earlier.

How can ligand specificity of OR1B1 be comprehensively profiled?

Comprehensive profiling of OR1B1 ligand specificity requires a multi-faceted approach combining experimental and computational methods:

• High-throughput screening approaches:

  • Development of cell-based reporter assays using OR1B1-expressing cells and cAMP or calcium indicators

  • Screening of diverse odorant libraries, systematically varying chemical structures to identify active compounds

  • Quantification of dose-response relationships for active ligands to determine EC₅₀ values

• Structure-activity relationship analysis:

  • Systematic modification of identified ligands to map essential functional groups

  • Creation of a database correlating chemical features with activation potency

  • Derivation of pharmacophore models that define the essential structural requirements for OR1B1 activation

• Computational prediction methods:

  • Implementation of machine learning approaches trained on experimental data

  • Molecular docking studies to predict binding poses and energetics

  • MD simulations to assess binding stability and induced conformational changes

• Data integration and visualization:

  • Construction of quantitative models relating chemical structure to activation potency

  • Development of predictive algorithms for identifying novel ligands

  • Creation of chemical space maps highlighting regions associated with OR1B1 activation

This comprehensive profiling would result in a detailed understanding of OR1B1's odor recognition profile, potentially revealing its biological role in detecting specific environmental chemicals.

What are the best approaches for analyzing contradictory data in OR1B1 binding studies?

When confronted with contradictory data in OR1B1 binding studies, researchers should implement a systematic troubleshooting and reconciliation strategy:

• Methodological assessment:

  • Compare experimental conditions across studies, including buffer composition, temperature, pH, and detergent selection

  • Evaluate differences in protein preparation methods, including expression systems and purification protocols

  • Assess assay formats (e.g., direct binding vs. functional activation) and their inherent limitations

• Technical validation:

  • Implement multiple orthogonal assay methods to verify binding results

  • Analyze positive and negative controls to ensure assay functionality

  • Conduct inter-laboratory validation studies using standardized protocols

• Data reanalysis and integration:

  • Develop statistical models that incorporate data from multiple studies

  • Perform meta-analysis to identify consistent trends across datasets

  • Use Bayesian approaches to update confidence in specific findings as new data emerges

• Biological context consideration:

  • Evaluate the potential impact of receptor oligomerization states on ligand binding properties

  • Assess the influence of membrane composition and cellular context on receptor function

  • Consider potential allosteric modulators that may explain discrepancies between studies

• Targeted experimental resolution:

  • Design experiments specifically addressing the points of contradiction

  • Systematically vary conditions to identify factors contributing to discrepant results

  • Use site-directed mutagenesis to test hypotheses about specific binding determinants

This systematic approach helps transform contradictory data from an obstacle into an opportunity for deeper mechanistic understanding of OR1B1 function.

How can OR1B1 research contribute to understanding ectopic olfactory receptor expression in non-olfactory tissues?

OR1B1 research can provide valuable insights into the emerging field of ectopic olfactory receptor expression through several research directions:

• Expression profiling:

  • Systematic analysis of OR1B1 expression across diverse tissue types using RNA-seq and proteomic approaches

  • Correlation of expression patterns with physiological states and disease conditions

  • Investigation of regulatory mechanisms controlling tissue-specific expression

• Functional characterization in non-olfactory contexts:

  • Development of tissue-specific OR1B1 reporter systems to identify activating ligands in physiological conditions

  • Investigation of downstream signaling pathways in different cellular contexts

  • Assessment of phenotypic consequences of OR1B1 manipulation in non-olfactory cells

• Comparative analysis:

  • Systematic comparison of OR1B1 signaling properties between olfactory and non-olfactory tissues

  • Evaluation of potential functional adaptations for non-olfactory roles

  • Investigation of evolutionary conservation of ectopic expression patterns

• Therapeutic implications:

  • Exploration of OR1B1 as a potential drug target in tissues where it plays a functional role

  • Development of tissue-selective OR1B1 modulators based on binding pocket characterization

  • Assessment of OR1B1 as a biomarker for specific disease states

Recent studies have demonstrated that ectopic olfactory receptors can function as chemical sensors in diverse contexts, responding to endogenous metabolites and regulating physiological processes outside the olfactory system . OR1B1 research may reveal similar non-canonical functions, potentially expanding our understanding of chemical sensing beyond traditional olfaction.

What novel technologies are emerging for high-throughput screening of OR1B1 ligands?

Cutting-edge technologies for high-throughput screening of OR1B1 ligands are revolutionizing the efficiency and scope of olfactory receptor research:

• Genome-wide pan-GPCR cell libraries:

  • Development of cell lines systematically expressing defined GPCRs including OR1B1

  • Implementation of automated screening platforms for rapid ligand identification

  • Integration with machine learning for predictive modeling of receptor-ligand interactions

• Microfluidic-based assay systems:

  • Miniaturized platforms enabling parallel screening of thousands of compounds

  • Reduced reagent consumption and increased throughput

  • Real-time monitoring of cellular responses to potential ligands

• CRISPR-based reporter systems:

  • Integration of fluorescent or luminescent reporters into endogenous OR1B1 genomic loci

  • Direct monitoring of receptor activation without artificial overexpression

  • Multiplexed screening across multiple olfactory receptors simultaneously

• Computational pre-screening:

  • Machine learning algorithms trained on existing olfactory receptor-ligand data to predict potential OR1B1 activators

  • Virtual screening of compound libraries prior to experimental validation

  • Integration of structural information and molecular dynamics simulation results to refine predictions

• Label-free detection technologies:

  • Surface plasmon resonance and related techniques for direct binding measurements

  • Mass spectrometry-based approaches for ligand identification

  • Impedance-based cellular assays for real-time monitoring of receptor activation

These technological advances are accelerating the pace of discovery in OR1B1 research, potentially revealing new biological functions and applications in various fields from medicine to artificial chemical sensing systems.

How might structural studies of OR1B1 contribute to artificial olfaction technology development?

Structural insights into OR1B1 can catalyze innovations in artificial olfaction technologies through several translational pathways:

• Biomimetic sensor design:

  • Development of synthetic receptors modeled after OR1B1 binding pocket architecture

  • Creation of peptide-based or polymeric materials that mimic key ligand recognition features

  • Implementation of biomimetic detection principles in electronic nose devices

• Structure-guided receptor engineering:

  • Modification of OR1B1 binding pocket to alter or expand ligand specificity

  • Development of OR1B1 variants with enhanced stability for integration into biosensor platforms

  • Creation of chimeric receptors combining features from multiple olfactory receptors for novel sensing properties

• Computational olfaction models:

  • Integration of structural data from OR1B1 and other olfactory receptors into predictive algorithms

  • Development of digital twins for virtual testing of odorant responses

  • Machine learning approaches trained on receptor structure-function relationships

• Hybrid bioelectronic systems:

  • Integration of purified OR1B1 or OR1B1-expressing cells with electronic transducers

  • Development of cell-free expression systems for on-demand production of functional OR1B1

  • Creation of long-term stable interfaces between biological sensing components and electronic signal processing

The detailed structural understanding of how OR1B1 recognizes and responds to specific odorants can inspire novel sensing technologies that approach the remarkable sensitivity and selectivity of biological olfaction, potentially transforming fields from environmental monitoring to food safety and medical diagnostics.